Jacobs & CO Bristol Myers Squibb CO Transaction History

Jacobs & CO

$1 Billion
Q3 2024

A detailed history of Jacobs & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jacobs & CO holds 4,469 shares of BMY stock, worth $257,637. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,469

Previous 27,289 83.62%

Holding current value

$257,637

Previous $1.13 Million 79.61%

% of portfolio

0.02%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$39.66 - $51.75 $905,041 - $1.18 Million	-22,820 Reduced 83.62%	4,469 $231,000
Q2 2024 Jul 12, 2024	SELL	$40.25 - $52.99 $4.07 Million - $5.35 Million	-101,039 Reduced 78.73%	27,289 $1.13 Million
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $48,651 - $55,161	1,014 Added 0.8%	128,328 $6.96 Million
Q4 2023 Jan 17, 2024	BUY	$48.48 - $57.85 $43,971 - $52,469	907 Added 0.72%	127,314 $6.53 Million
Q3 2023 Oct 13, 2023	BUY	$57.89 - $64.73 $16,093 - $17,994	278 Added 0.22%	126,407 $7.34 Million
Q2 2023 Jul 11, 2023	BUY	$63.71 - $70.74 $35,359 - $39,260	555 Added 0.44%	126,129 $8.07 Million
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $173,540 - $196,833	2,641 Added 2.15%	125,574 $8.7 Million
Q4 2022 Jan 13, 2023	SELL	$68.48 - $81.09 $59,920 - $70,953	-875 Reduced 0.71%	122,933 $8.85 Million
Q3 2022 Oct 11, 2022	SELL	$0.13 - $76.84 $49 - $29,506	-384 Reduced 0.31%	123,808 $8.8 Million
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $810,947 - $893,136	-11,167 Reduced 8.25%	124,192 $9.56 Million
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $46,847 - $56,174	-762 Reduced 0.56%	135,359 $9.89 Million
Q4 2021 Jan 21, 2022	BUY	$53.63 - $62.52 $659,702 - $769,058	12,301 Added 9.93%	136,121 $8.49 Million
Q3 2021 Oct 13, 2021	BUY	$59.17 - $69.31 $706,193 - $827,214	11,935 Added 10.67%	123,820 $7.33 Million
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $2,724 - $2,966	44 Added 0.04%	111,885 $7.48 Million
Q1 2021 Apr 05, 2021	BUY	$59.34 - $66.74 $194,101 - $218,306	3,271 Added 3.01%	111,841 $7.06 Million
Q4 2020 Jan 12, 2021	BUY	$57.74 - $65.43 $288,988 - $327,477	5,005 Added 4.83%	108,570 $6.73 Million
Q3 2020 Dec 03, 2020	BUY	$57.43 - $63.64 $524,852 - $581,605	9,139 Added 9.68%	103,565 $6.24 Million
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $434,229 - $507,656	7,921 Added 9.16%	94,426 $5.55 Million
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $332,316 - $482,933	-7,162 Reduced 7.65%	86,505 $4.82 Million
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $1.26 Million - $1.65 Million	25,637 Added 37.68%	93,667 $6.01 Million
Q3 2019 Nov 04, 2019	BUY	$42.77 - $50.71 $101,878 - $120,791	2,382 Added 3.63%	68,030 $3.45 Million
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $39,533 - $43,715	886 Added 1.37%	65,648 $2.98 Million
Q1 2019 Apr 29, 2019	BUY	$45.12 - $53.8 $56,625 - $67,519	1,255 Added 1.98%	64,762 $3.09 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $198,355 - $257,219	-4,068 Reduced 6.02%	63,507 $3.3 Million
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $8,223 - $9,275	-149 Reduced 0.22%	67,575 $4.2 Million
Q2 2018 Jul 19, 2018	SELL	$50.53 - $62.98 $70,388 - $87,731	-1,393 Reduced 2.02%	67,724 $3.75 Million
Q1 2018 Apr 30, 2018	BUY	$59.92 - $68.98 $22,769 - $26,212	380 Added 0.55%	69,117 $4.37 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $57,602 - $62,801	961 Added 1.42%	68,737 $4.17 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $3.74 Million - $4.32 Million	67,776	67,776 $4.32 Million

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs & CO with notifications on news.

Account